ARS Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $233.2M
Liabilities Breakdown FY2023
Total Liabilities: $2.4M
Asset Breakdown
Total Assets: $233.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $71.0M | 30.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $574.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $161.6M | 69.3% |
Liabilities Breakdown
Total Liabilities: $2.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $759.0K | 31.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.7M | 68.7% |